Delivery Order SPE2DB22D3004-SPE2DB25FQ95M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of TUKYSA 150 mg tablets (120 count) with a contract value of $12,697.69. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA is a prescription oncology medication, reflecting the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TUKYSA 150 mg tablets in quantities of 120 units. This competitive, non-set-aside delivery order is valued at $50,790.76 with a firm fixed price and is scheduled for completion by October 20, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a ceiling value of $19,012.08. This firm fixed-price delivery order, with an ultimate completion date of October 20, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,306.64 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of TUKYSA 50 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by September 26, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a $12,697.69 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TUKYSA 150 mg tablets (120 count) with a completion date of October 15, 2025. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a completion date of October 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ95MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TUKYSA 150 mg tablets (60-unit packs) with a contract value of $12,674.74 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by October 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to deliver specialized medications across multiple therapeutic domains, including oncology treatments such as TUKYSA, through open competition with the Defense Logistics Agency. The award reflects the vendor's established role as a primary pharmaceutical supplier within the DLA Medical Supply Chain, serving defense health requirements for military personnel, veterans, and other government healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 9/26/25 |